AREAS OF SPECIALTY:
Genetics of exceptional longevity
Gerotherpuetics
Metabolism of aging
“Targeting Healthspan has personal (to elderly, HIV patients, cancer therapy survivors and astronauts) benefits and longevity dividends. We cannot afford not to do it.”
Nir Barzilai, M.D.
Director of the Institute for Aging Research at Albert Einstein College of Medicine
Director of the Paul F. Glenn Center for the Biology of Human Aging Research
Board Member, American Federation for Aging Research (AFAR)
Dr. Nir Barzilai is the director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is the Ingeborg and Ira Leon Rennert Chair of Aging Research, professor in the Departments of Medicine and Genetics, and member of the Diabetes Research Center and of the Divisions of Endocrinology & Diabetes and Geriatrics.
FOCUS AREAS
Centenarians. Dr. Barzilai hypothesizes that centenarians have protective genes that allows the delay of aging and protect against age-related diseases. Dr. Barzilai leads a program in which he observes phenotypes, DNA, and cells from the Ashkenazi Jewish families with exceptional longevity. Through this initiative, he has observed at Einstein over 2600 samples of exceptional longevity, (of which ~670 are centenarians) discovering underling genomic differences associated with longevity along the way.
Dr. Barzilai founded the Longevity Genes Project (LGP) which is a cross-sectional, on-going collection of blood and phenotype from families with centenarian proband.
His lab has also identified several central pathways that specifically alter body fat distribution, insulin action and secretion by intraventricular or hypothalamic administration of several peptides that are modulated by aging including: Leptin, IGF-1, IGFBP3 and resveratrol.
Awards and Honors
Dr. Barzilai holds an NIH Merit award that focuses on the metabolic decline of aging, hypothesizing that the brain leads this decline.
aging critical publications
Barzilai N, Atzmon G, Schechter C, Schaefer E, Lipton R, Cheng S, Shuldiner AR. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA. 2003. 290:2030-40
Atzmon G, … , Barzilai N, Govindaraju DR, Suh Y. Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proc Natl Acad Sci U S A. 2009 Dec 4 PMC2868292
Ismail K, Nussbaum L, Sebastiani P, Andersen S, Perls T, Barzilai N, Milman S. Compression of Morbidity Is Observed Across Cohorts with Exceptional Longevity. J Am Geriatr Soc. 2016 Aug;64(8):1583-91. doi: 10.1111/jgs.14222. Epub 2016 Jul 5. PMID: 27377170 PMC4988893
Cobb LJ, … Barzilai N, Cohen P. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging (Albany NY). 2016 Apr 10. PMCID: PMC4925829.
Huffman DM, … Barzilai N. Central insulin-like growth factor-1 (IGF-1) restores whole-body insulin action in a model of age-related insulin resistance and IGF-1 decline. Aging Cell. 2015 Nov 4. PMCID: PMC4717281